Education
About Us
Working with TipRanks
Follow Us
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
CBI Stock Chart & Stats
Day’s Range― - ―
52-Week Range28.20 - 49.00
Previous CloseN/A
Volume5.47K
Average Volume (3M)37.48K
Market Cap
47.99M
Enterprise Value63.94M
Total Cash (Recent Filing)13.36M
Total Debt (Recent Filing)35.76M
Price to Earnings (P/E)―
Beta0.59
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Mar 29, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding156,846,200
10 Day Avg. Volume26,364
30 Day Avg. Volume37,478
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.28
Price to Sales (P/S)0.00
P/FCF Ratio-7.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Clal Biotech News
PremiumCompany Announcements
Mediwound’s EscharEx Shows Promising Results in Phase 3 Trial
PremiumCompany Announcements
Clal Biotech Completes Elicio Divestment and Initiates Loan RepaymentCBI FAQ
What was Clal Biotechnology Industries Ltd’s price range in the past 12 months?
Clal Biotechnology Industries Ltd lowest stock price was 28.20 and its highest was 49.00 in the past 12 months.
What is Clal Biotechnology Industries Ltd’s market cap?
Clal Biotechnology Industries Ltd’s market cap is 47.99M.
When is Clal Biotechnology Industries Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clal Biotechnology Industries Ltd’s earnings last quarter?
Currently, no data Available
Is Clal Biotechnology Industries Ltd overvalued?
According to Wall Street analysts Clal Biotechnology Industries Ltd’s price is currently Overvalued.
Does Clal Biotechnology Industries Ltd pay dividends?
Clal Biotechnology Industries Ltd pays a Notavailable dividend of 22.372 which represents an annual dividend yield of N/A. See more information on Clal Biotechnology Industries Ltd dividends here
What is Clal Biotechnology Industries Ltd’s EPS estimate?
Clal Biotechnology Industries Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clal Biotechnology Industries Ltd have?
Clal Biotechnology Industries Ltd has 156,846,200 shares outstanding.
What happened to Clal Biotechnology Industries Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Clal Biotechnology Industries Ltd?
Currently, no hedge funds are holding shares in IL:CBI
Company Description
Clal Biotechnology Industries Ltd
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It invests between $0.5 million and $10 million per company. It takes a seat on the board of directors of the companies it invests in. It invests through personal capital of its management. The firm acts as a lead investor and major shareholder in its portfolio companies. Clal Biotechnology Industries Ltd. was founded in July, 1998 and is based in Tel Aviv, Israel with an additional office in Cambridge, Massachusetts. It operates as a former subsidiary of Clal Industries and Investments Ltd.